Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

New compounds may help treat prostate issues without affecting androgen receptors.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

GI197111X is best dissolved in Capmul MCM for trials.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.